Type 1 Diabetes TrialNet Clinical Centers (U01)

 

Type 1 Diabetes TrialNet is an international consortium of clinical research centers aimed at the delay or prevention of type 1 diabetes (T1D). This opportunity will provide infrastructure support for TrialNet Clinical Centers, allowing them to recruit, treat, and follow subjects in TrialNet studies and trials. In addition, funding will be provided for Clinical Centers to support Affiliate Sites. In addition to this opportunity, a separate, new TrialNet unit is planned, the Clinical Network Hub (CNH). The CNH will focus on the coordination and enhancement of screening and recruiting activities.

Deleted 12/28/2013 (Archived.) RFA-DK-13-010 Agency: Department of Health and Human Services
Office: National Institutes of Health Cooperative Agreement Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Only Non-domestic (non-U.S.) Entities (Foreign Institutions) located in North America are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Only foreign components, as defined in the NIH Grants Policy Statement, that are located in North America are allowed. 11/27/2013 This program does not have cost sharing or matching requirements. NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-010.html FBOWebmaster@OD.NIH.GOV $6,500,000.00 Awards up to $200,000.00